Venue
This year's event will be held in Boston, MA at the Hotel Commonwealth.
Dedicated Room Block
We are pleased to announce that for 3rd ADC Payloads Summit, we have a dedicated room block at the conference hotel, Hotel Commonwealth.
We are offering a nightly room rate of $369++ for the nights of Tuesday, November 3 to Friday, November 6.
The booking reservation contact number is: (1 866) 784-4000 – please quote / refer to ‘63073 - 3rd ADC Payload Summit’ if you are calling in.
Reservations must be made by Tuesday, October 13 which is the cutoff date. However, please note due to high demand, rooms may sell out before the cutoff date so we do recommend you book your accommodation sooner rather than later.
Please email Olivia Holden at Olivia.holden@hansonwade.com if you have any questions or queries regarding the room block.
Important Note - Fraudulent Accommodation Booking Scams
We have been made aware that there are third-party companies contacting our conference attendees claiming to represent Hanson Wade Group with fraudulent hotel booking schemes.
Hanson Wade Group does not work with any third parties and accommodation information will only come directly from your Event Manager. For your safety, please only book your accommodation through official links provided by Hanson Wade Group. Learn more in our full accommodation policy: Accommodation Policy - Hanson Wade Group.
Explore the Agenda
Discover the complete agenda featuring novel payload mechanisms, dual-payload ADCs, resistance biology, therapeutic index optimisation, and the industry leaders redefining ADC payload innovation.
Partner With the ADC Payload Community
Position your organization alongside 70+ senior payload, chemistry, biology, and translational R&D leaders actively seeking technologies, expertise, and collaborations to accelerate next-generation ADC development.
Join 70+ ADC Payload Leaders
Connect with scientists and decision-makers from biopharma and biotech companies tackling the industry's biggest challenges, from overcoming resistance and diversifying payloads to improving clinical translation.